Elexacaftor/Tezacaftor/Ivacaftor Treatment Accessibility and Mental Health: Reducing Anxiety in People With Cystic Fibrosis
Limited access to modulator therapies is associated with higher depression and anxiety symptoms among pwCF. Addressing these barriers is critical to improving their well-being.
Authors
- Merve Selçuk (ORCID: https://orcid.org/0000-0002-2146-3966)
- Ceren Ayça Yıldız (ORCID: https://orcid.org/0000-0003-1964-4263)
- Yasemi̇n Gökdemi̇r (ORCID: https://orcid.org/0000-0002-0853-7932)
- Şeyda Karabulut (ORCID: https://orcid.org/0000-0002-4606-8946)
- Fazi̇let Karakoç (ORCID: https://orcid.org/0000-0001-8518-4715)
- Burcu Uzunoğlu (ORCID: https://orcid.org/0009-0004-3994-4399)
- Mine Kalyoncu (ORCID: https://orcid.org/0000-0002-4594-2822)
- Ela Erdem Eralp (ORCID: https://orcid.org/0000-0001-8829-3431)
- Bulent Taner Karadag (ORCID: https://orcid.org/0000-0003-0605-8871)
- Pınar Ergenekon (ORCID: https://orcid.org/0000-0003-0228-9832)
- Damla Kocaman
- Neval Meti̇n Çakar (ORCID: https://orcid.org/0000-0001-7943-0967)
- Gamze Taştan
Institutions
- Marmara University (TR)
Publication Details
- Journal
- Pediatric Pulmonology
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1002/ppul.71037
- Citations
- 1
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 1.52